SREBF2 and heart disorder: However, a paradoxical feedback mechanism by which statins induce HMGCR stability and SREBP2-mediated compensation of cholesterol biosynthesis often causes lower therapeutic efficacy of statins in the treatment of heart disease and cancer [18,19,20].